<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39401213</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2767-3375</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PLOS global public health</Title><ISOAbbreviation>PLOS Glob Public Health</ISOAbbreviation></Journal><ArticleTitle>To vaccinate or not to vaccinate? Experiences of COVID-19 vaccine uptake among people living with non-communicable diseases in Ghana: A qualitative study.</ArticleTitle><Pagination><StartPage>e0003820</StartPage><MedlinePgn>e0003820</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0003820</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pgph.0003820</ELocationID><Abstract><AbstractText>Following the development of a vaccine for COVID-19, the expectation was instantaneous widespread distribution and uptake to halt further spread, severe illness and deaths from the virus. However, studies show very low uptake, especially in resource-poor settings, and little is documented about the drivers of vaccine uptake in populations classified as high-risk. In this study, we explored access and uptake of COVID-19 vaccines among people living with non-communicable diseases (PLWNCDs) in Ghana. A qualitative study using in-depth interviews and focus group discussions was conducted among adults (&gt;18 years) PLWNCDs stratified by sex, age, and type of non-communicable diseases (NCDs) at the community level (non-users of the health service) and health facility levels. Purposive sampling was used to select eligible participants. Topic guides were used to facilitate the face-to-face in-depth interviews and focus group discussions. The interviews and discussions were all digitally audio recorded. All transcripts and field notes were thematically analysed. Overall, 62 participants were recruited for this study. Family members, friends/peers, health workers and media were identified as the main sources of information for COVID-19 vaccines. Several barriers that mediated access to the COVID-19 vaccines in Ghana were reported including mistrust of vaccine efficacy and fears of vaccine side-effects, long distance to and waiting hours at vaccination centres, shortages of vaccines at vaccination centres and non-prioritization of NCD patients for the vaccine. To improve uptake, intensified education and sensitization, house-to-house vaccination, expansion of vaccination centers and increased supply of vaccines were recommended by participants. Compared to studies elsewhere, misinformation and disinformation were not major causes of vaccine hesitancy. If policymakers can improve community-based vaccine delivery, reduce queues and waiting times, prioritize PLWNCDs and other vulnerable groups, and improve sensitization and communication-our findings suggest there will be major improvements in COVID-19 vaccine coverage in Ghana.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baatiema</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-3286-6565</Identifier><AffiliationInfo><Affiliation>Department of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kunfah</LastName><ForeName>Sheba M P</ForeName><Initials>SMP</Initials><AffiliationInfo><Affiliation>Department of Health Policy, Planning and Management, School of Public Health, University of Ghana, Legon, Accra.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanuade</LastName><ForeName>Olutobi A</ForeName><Initials>OA</Initials><Identifier Source="ORCID">0000-0003-4972-1098</Identifier><AffiliationInfo><Affiliation>Department of Population Health Sciences, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, Utah, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Luke N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abimbola</LastName><ForeName>Seye</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1294-3850</Identifier><AffiliationInfo><Affiliation>School of Public Health, Faculty of Medicine and Health, University of Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de-Graft Aikins</LastName><ForeName>Ama</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Advanced Studies, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koram</LastName><ForeName>Kwadwo A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruk</LastName><ForeName>Margaret E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLOS Glob Public Health</MedlineTA><NlmUniqueID>9918283779606676</NlmUniqueID><ISSNLinking>2767-3375</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>22</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>13</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39401213</ArticleId><ArticleId IdType="pmc">PMC11472953</ArticleId><ArticleId IdType="doi">10.1371/journal.pgph.0003820</ArticleId><ArticleId IdType="pii">PGPH-D-23-02073</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Briefing WM. WHO Director-General’s opening remarks at the media briefing on COVID-19. World Health Organization. 2020. p. 1.</Citation></Reference><Reference><Citation>Barone MTU, Ngongo B, Harnik SB, de Oliveira LX, Végh D, de Luca PV, et al.. COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis. Diabetes Res Clin Pract. 2021;171. doi: 10.1016/j.diabres.2020.108587</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2020.108587</ArticleId><ArticleId IdType="pmc">PMC7724978</ArticleId><ArticleId IdType="pubmed">33307134</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikoloski Z, Alqunaibet AM, Alfawaz RA, Almudarra SS, Herbst CH, El-Saharty S, et al.. Covid-19 and non-communicable diseases: evidence from a systematic literature review. BMC Public Health. 2021;21:1–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8178653</ArticleId><ArticleId IdType="pubmed">34090396</ArticleId></ArticleIdList></Reference><Reference><Citation>Oduro-Mensah E, Tetteh J, Adomako I, Adjei-Mensah E, Owoo C, Yawson AO, et al.. Clinical features of COVID-19 in Ghana: Symptomatology, illness severity and comorbid non-communicable diseases. Ghana Med J. 2020;54:23–32. doi: 10.4314/gmj.v54i4s.5</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/gmj.v54i4s.5</ArticleId><ArticleId IdType="pmc">PMC8087366</ArticleId><ArticleId IdType="pubmed">33976438</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang AY, Cullen MR, Harrington RA, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. J Intern Med. Blackwell Publishing Ltd; 2021;289: p. 450–62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7675448</ArticleId><ArticleId IdType="pubmed">33020988</ArticleId></ArticleIdList></Reference><Reference><Citation>Group C-19 S. Characteristics of COVID-19 patients dying in Italy Report based on available data on March 20 th, 2020. COVID-19 Surveillance Group. 2020;099:4–8.</Citation></Reference><Reference><Citation>WHO. THE IMPACT OF THE COVID-19 PANDEMIC ON NONCOMMUNICABLE DISEASE RESOURCES AND SERVICES: RESULTS OF A RAPID ASSESSMENT. 2020.</Citation></Reference><Reference><Citation>Li Y, Tenchov R, Smoot J, Liu C, Watkins S, Zhou Q. A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development. ACS Cent Sci. 2021;7:512–33. doi: 10.1021/acscentsci.1c00120</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.1c00120</ArticleId><ArticleId IdType="pmc">PMC8029445</ArticleId><ArticleId IdType="pubmed">34056083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. International Journal of Infectious Diseases. 2022;114:252–60. doi: 10.1016/j.ijid.2021.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.11.009</ArticleId><ArticleId IdType="pmc">PMC8595975</ArticleId><ArticleId IdType="pubmed">34800687</ArticleId></ArticleIdList></Reference><Reference><Citation>Troiano G, Nardi A. Vaccine hesitancy in the era of COVID-19. Public Health. 2021;194:245–51. doi: 10.1016/j.puhe.2021.02.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.puhe.2021.02.025</ArticleId><ArticleId IdType="pmc">PMC7931735</ArticleId><ArticleId IdType="pubmed">33965796</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 Vaccine Acceptance, Intention, and Hesitancy: A Scoping Review. Front Public Health. 2021;9. doi: 10.3389/fpubh.2021.698111</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.698111</ArticleId><ArticleId IdType="pmc">PMC8414566</ArticleId><ArticleId IdType="pubmed">34485229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C, Tu P, Beitsch LM. Confidence and receptivity for covid‐19 vaccines: A rapid systematic review. Vaccines (Basel). 2021;9:1–32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7823859</ArticleId><ArticleId IdType="pubmed">33396832</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors. Prev Med (Baltim). 2021;150:106694. doi: 10.1016/j.ypmed.2021.106694</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2021.106694</ArticleId><ArticleId IdType="pmc">PMC8217737</ArticleId><ArticleId IdType="pubmed">34171345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ojewale LY, Mukumbang FC. COVID-19 vaccine hesitancy among Nigerians living with non-communicable diseases: A qualitative study. BMJ Open. 2023;13. doi: 10.1136/bmjopen-2022-065901</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-065901</ArticleId><ArticleId IdType="pmc">PMC9895914</ArticleId><ArticleId IdType="pubmed">36731928</ArticleId></ArticleIdList></Reference><Reference><Citation>Health MOF. Ministry of Health, Ghana Ghana Covid-19 Emergency Response on Vaccines Second Additional Financing (P176485) Environmental and Social Management Framework (Esmf). 2021;</Citation></Reference><Reference><Citation>Amponsah-Tabi S, Djokoto R, Opoku S, Senu E, Boakye DK, Azanu WK, et al.. Knowledge, attitude and acceptability of COVID-19 vaccine among residents in rural communities in Ghana: a multi-regional study. BMC Infect Dis. 2023;23:1–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9887558</ArticleId><ArticleId IdType="pubmed">36721102</ArticleId></ArticleIdList></Reference><Reference><Citation>Amo-Adjei J, Nurzhynska A, Essuman R, Lohiniva AL. Trust and willingness towards COVID-19 vaccine uptake: a mixed-method study in Ghana, 2021. Archives of Public Health. 2022;80. doi: 10.1186/s13690-022-00827-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13690-022-00827-0</ArticleId><ArticleId IdType="pmc">PMC8860287</ArticleId><ArticleId IdType="pubmed">35189963</ArticleId></ArticleIdList></Reference><Reference><Citation>Adjaottor ES, Addo FM, Ahorsu FA, Chen HP, Ahorsu DK. Predictors of COVID-19 Stress and COVID-19 Vaccination Acceptance among Adolescents in Ghana. Int J Environ Res Public Health. 2022;19. doi: 10.3390/ijerph19137871</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19137871</ArticleId><ArticleId IdType="pmc">PMC9266030</ArticleId><ArticleId IdType="pubmed">35805530</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. World Health Organization. 2022. p. 1–5.</Citation></Reference><Reference><Citation>Agyekum MW, Afrifa-Anane GF, Kyei-Arthur F, Addo B. Acceptability of COVID-19 Vaccination among Health Care Workers in Ghana. Adv Public Health. 2021;2021.</Citation></Reference><Reference><Citation>O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for reporting qualitative research: A synthesis of recommendations. Academic Medicine. 2014;89:1245–51. doi: 10.1097/ACM.0000000000000388</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACM.0000000000000388</ArticleId><ArticleId IdType="pubmed">24979285</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao S, Friedman DB, Tam CC, Zeng C, Li X. Vaccine acceptance among college students in South Carolina: Do information sources and trust in information make a difference? medRxiv [Internet]. 2020; http://www.ncbi.nlm.nih.gov/pubmed/33300004</Citation><ArticleIdList><ArticleId IdType="pubmed">35427458</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain MS, Islam MS, Pardhan S, Banik R, Ahmed A, Islam MZ, et al.. Beliefs, barriers and hesitancy towards the COVID-19 vaccine among Bangladeshi residents: Findings from a cross-sectional study. PLoS One. 2022;17. doi: 10.1371/journal.pone.0269944</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0269944</ArticleId><ArticleId IdType="pmc">PMC9398020</ArticleId><ArticleId IdType="pubmed">35998135</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrifa-Anane GF, Larbi RT, Addo B, Agyekum MW, Kyei-Arthur F, Appiah M, et al.. Facilitators and barriers to COVID-19 vaccine uptake among women in two regions of Ghana: A qualitative study. PLoS One. 2022;17. doi: 10.1371/journal.pone.0272876</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272876</ArticleId><ArticleId IdType="pmc">PMC9385066</ArticleId><ArticleId IdType="pubmed">35976969</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyten J, Bruyneel L, van Hoek AJ. Assessing vaccine hesitancy in the UK population using a generalized vaccine hesitancy survey instrument. Vaccine. 2019;37:2494–501. doi: 10.1016/j.vaccine.2019.03.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2019.03.041</ArticleId><ArticleId IdType="pubmed">30940484</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahorsu DK, Lin CY, Alimoradi Z, Griffiths MD, Chen HP, Broström A, et al.. Cyberchondria, Fear of COVID-19, and Risk Perception Mediate the Association between Problematic Social Media Use and Intention to Get a COVID-19 Vaccine. Vaccines (Basel). 2022;10. doi: 10.3390/vaccines10010122</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010122</ArticleId><ArticleId IdType="pmc">PMC8779372</ArticleId><ArticleId IdType="pubmed">35062783</ArticleId></ArticleIdList></Reference><Reference><Citation>Rad MK, Fakhri A, Stein LAR, Araban M. Health-care staff beliefs and coronavirus disease 2019 vaccinations: A cross-sectional study from Iran. Asian Journal of Social Health and Behavior. 2022;5:40–6.</Citation></Reference><Reference><Citation>Nawas GT, Zeidan RS, Edwards CA, El-Desoky RH. Barriers to COVID-19 Vaccines and Strategies to Improve Acceptability and Uptake. J Pharm Pract. SAGE Publications Inc.; 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047593</ArticleId><ArticleId IdType="pubmed">35465688</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardin B, Graboyes M, Kosty D, Cioffi C. Vaccine decision making among people who inject drugs: Improving on the WHO’s 3C model of vaccine hesitancy. Prev Med Rep. 2023;35. doi: 10.1016/j.pmedr.2023.102341</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pmedr.2023.102341</ArticleId><ArticleId IdType="pmc">PMC10428103</ArticleId><ArticleId IdType="pubmed">37593355</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamysetty S, Babu GR, Sahu B, Shapeti S, Ravi D, Lobo E, et al.. Predictors of COVID-19 Vaccine Confidence: Findings from Slums of Four Major Metro Cities of India. Vaccines (Basel). 2022;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8781952</ArticleId><ArticleId IdType="pubmed">35062720</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Ghana shares success story in COVID-19 vaccine rollout with Cote d’Ivoire. WHO Africa. 2021 Jun 1;</Citation></Reference><Reference><Citation>Abuosi AA, Braimah M. Patient satisfaction with the quality of care in Ghana’s health-care institutions: A disaggregated approach. Int J Pharm Healthc Mark. 2019;13:160–70.</Citation></Reference><Reference><Citation>Cochran AL, Wang J, Prunkl L, Oluyede L, Wolfe M, McDonald N. Access to the COVID-19 Vaccine in Centralized and Dispersed Distribution Scenarios. Findings. 2021;</Citation></Reference><Reference><Citation>Quakyi NK. Ghana’s COVID-19 vaccine rollout is struggling to keep up with its great start. The Conversation. 2021;</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>